Sub-Saharan Africa (IDA & IBRD countries) vs Tunisia: Immunization, Hib3
Immunization, Hib3 over time
- Sub-Saharan Africa (IDA & IBRD countries)
- Tunisia
How they compare
Tunisia currently reports 97.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 23.0%.
That makes Tunisia's figure about 1.3 times Sub-Saharan Africa (IDA & IBRD countries)'s.
The two have swapped places 2 times across 17 shared years of data; in 2003 it was Tunisia ahead.
Sub-Saharan Africa (IDA & IBRD countries) ranks 32nd and Tunisia ranks 29th of 43 groups.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sub-Saharan Africa (IDA & IBRD countries) | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.1% | 91.0% | 75.9% | Tunisia |
| 2010s | 69.5% | 91.7% | 22.1% | Tunisia |
| 2020s | 73.4% | 97.0% | 23.6% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Sub-Saharan Africa (IDA & IBRD countries) or Tunisia?
- Tunisia, at 97.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between Sub-Saharan Africa (IDA & IBRD countries) and Tunisia?
- 23.0%, with Tunisia ahead.
- How many years of comparable data are there for Sub-Saharan Africa (IDA & IBRD countries) and Tunisia?
- 17 years are reported by both, from 2003 to 2024.
- How do Sub-Saharan Africa (IDA & IBRD countries) and Tunisia rank globally for immunization, hib3?
- Sub-Saharan Africa (IDA & IBRD countries) ranks 32nd and Tunisia ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.